MedWatch

”It is the worst e-mail I have received in 22 years”

Medwatch offers a profile on the man who ensures the continued success of the Danish diabetes giant Novo Nordisk, Peter Kurtzhals, Senior Vice President of diabetes R&D.

North of Copenhagen, just outside of the small town of Måløv, is an even smaller town with growing pains. In the middle of the town is a banana-shaped building surrounded by large factory buildings.

This is where the foundation for the Novo Nordisk’s impressive growth story has been, and will continue to be, laid. It is the head quarters of the company’s R&D efforts within diabetes - and it is the domain of Peter Kurtzhals. Boasting the title ‘Senior Vice President of Diabetes R&D’ he has been responsible for laying the aforementioned foundation since 2001.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Her er de vigtigste nyheder fra MedWatch i uge 39

Et konsortium står til at overtage Ferrosan Medical Devices, der kan være klar til en børsnotering inden for en femårig tidshorisont. Derudover fortsætter kampen om medarbejderne i branchen, mens Novo Nordisk har indgået en ny aftale. Gik du glip af noget?

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier